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a  b  s  t  r  a  c  t
Organophosphorus  (OP)  insecticide  self-poisoning  is  responsible  for about  one-quarter  of  global  sui-
cides.  Treatment  focuses  on  the  fact  that  OP  compounds  inhibit  acetylcholinesterase  (AChE);  however,
AChE-reactivating  drugs  do  not  beneﬁt  poisoned  humans.  We  therefore  studied  the  role  of  solvent  cofor-
mulants  in  OP  toxicity  in  a  novel  minipig  model  of  agricultural  OP poisoning.  Gottingen  minipigs  were
orally  poisoned  with  clinically  relevant  doses  of  agricultural  emulsiﬁable  concentrate  (EC)  dimethoate,
dimethoate  active  ingredient  (AI)  alone,  or solvents.  Cardiorespiratory  physiology  and  neuromuscular
(NMJ)  function,  blood  AChE  activity,  and  arterial  lactate  concentration  were  monitored  for  12  h to assess
poisoning  severity.  Poisoning  with  agricultural  dimethoate  EC40,  but  not  saline,  caused  respiratory  arrest
within  30  min,  severe  distributive  shock  and  NMJ  dysfunction,  that  was  similar  to human  poisoning.  Mean
arterial  lactate  rose  to 15.6  [SD  2.8]  mM  in poisoned  pigs  compared  to 1.4  [0.4]  in  controls.  Moderate  tox-
icity resulted  from  poisoning  with  dimethoate  AI  alone,  or the  major  solvent  cyclohexanone.  Combining
dimethoate  with  cyclohexanone  reproduced  severe  poisoning  characteristic  of  agricultural  dimethoate
EC  poisoning.  A  formulation  without  cyclohexanone  showed  less  mammalian  toxicity.  These  results  indi-
cate  that  solvents  play  a  crucial  role  in  dimethoate  toxicity.  Regulatory  assessment  of  pesticide  toxicity
should  include  solvents  as  well  as  the  AIs  which  currently  dominate  the  assessment.  Reformulation  of  OP
insecticides  to ensure  that  the agricultural  product  has  lower  mammalian  toxicity  could result  in fewer
deaths  after  suicidal  ingestion  and  rapidly  reduce  global  suicide  rates.
© 2012 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Pesticides are used extensively in tropical agriculture to increase
crop yield (World Health Organization, 1990). However, this use
has a cost: pesticide self-poisoning is a major public health prob-
lem (Jeyaratnam, 1990; Eddleston and Phillips, 2004), killing at
least 250–370,000 people every year (Gunnell et al., 2007a).
Organophosphorus (OP) insecticides, acting as acetylcholinesterase
(AChE) inhibitors, are the most important, being responsible for
more than 2/3 of deaths due to their high toxicity and widespread
∗ Corresponding author at: Clinical Pharmacology Unit, QMRI E3.20, 47 Little
France Cres, Edinburgh, EH16 4TJ, UK.
E-mail address: m.eddleston@ed.ac.uk (M.  Eddleston).
use (Eddleston, 2000). Medical treatment is difﬁcult, with case
fatality often over 20% (Eddleston, 2000). We  recently found that
the speciﬁc antidote, the AChE reactivator pralidoxime, offers little
beneﬁt to patients severely poisoned with Environmental Pro-
tection Agency (EPA)/World Health Organization (WHO) Class II
‘moderately toxic’ OP insecticides (Eddleston et al., 2009a; Buckley
et al., 2011). This suggests that other components of the agricultural
OP formulations might be necessary for acute toxicity.
Although toxicity from coformulants is recognised for
glyphosate herbicides (Bradberry et al., 2004), their role in
the acute mammalian toxicity of the emulsiﬁable concentrate (EC)
insecticide formulations used in agriculture and ingested in self-
harm has been explored only once (Casida and Sanderson, 1961)
and then apparently forgotten. Medical textbooks do not consider
coformulants to be a clinical issue in OP insecticide poisoning. Of
0300-483X/$ – see front matter ©  2012 Elsevier Ireland Ltd. All rights reserved.
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note, coformulants are usually present to improve the agricultural
usability of the insecticide, not for their insecticidal activity.
To explore the role of coformulants in OP insecticide poisoning,
we developed a Gottingen minipig (Forster et al., 2010b)  model of
poisoning with dimethoate EC40, the agricultural formulation of
dimethoate that contains 400 g/l dimethoate active ingredient [AI]
as well as coformulants. We  chose the Gottingen minipig because
from histological, anatomical and physiological perspectives, it is
much closer to humans than rodents (Matute-Bello et al., 2008;
Svendsen, 2006). Furthermore, due to similarities to human bio-
chemistry and drug elimination, the Gottingen minipig has become
an increasingly important model species for pharmacological and
toxicological studies (Soucek et al., 2001; Svendsen, 2006; Forster
et al., 2010a).  The large size of the species has several further advan-
tages including: a longer, and more clinically relevant, time course
of study for most diseases; repeated sampling of blood and of the
gas exchanging regions of the lung using bronchoalveolar lavage;
and the use of readily available clinical equipment to measure phys-
iology and for imaging.
The EPA/WHO Class II ‘moderately toxic’ insecticide dimethoate
is a major clinical problem (Eddleston et al., 2005) with a case fatal-
ity of 20.6% in one large prospective case series (Dawson et al.,
2010); it is likely to become more widely used following the Food
and Agriculture Organization (FAO)’s advice to withdraw the more
toxic Class I OP pesticides from agricultural practice (Food and
Agriculture Organization of the United Nations, 2002) and recent
favourable reviews by the EPA and FAO (Food and Agricultural
Organization, 2005; US Environmental Protection Agency Ofﬁce of
Pesticide Programs, 2008). The EC40 formulation contains cyclo-
hexanone, xylene, and a surfactant, as well as dimethoate (Table 1).
Human poisoning with dimethoate EC40 is characterised by respi-
ratory failure, distributive shock, cardiovascular collapse, and
neuromuscular dysfunction (Eddleston et al., 2005; Davies et al.,
2008).
We aimed to determine whether the dimethoate AI alone was
responsible for the mammalian toxicity of agricultural dimethoate
EC40 or whether other components of the formulation were nec-
essary.
2. Methods
The study was performed under Home Ofﬁce Licence after institutional ethics
review in 27 adult male Göttingen minpigs (Ellegaard Minipigs ApS, Dalmose,
Denmark) with mean weight 20.1 (SD 3.3) kg. Animals were drug-naïve and bar-
rier  bred, and shown to be free of infections before shipment to Edinburgh. Animals
were kept in pens with free access to food scattered in their bedding and water
under the care of institutional veterinary surgeons. Food was withheld for one night
before a study. The animals were treated in accordance with the Animals (Scientiﬁc
Procedures) Act of 1986.
2.1. Study design
The study involved three experiments: a comparison of dimethoate EC40 poi-
soning with saline placebo, a comparison of dimethoate AI and/or cyclohexanone
with the results of this previous study, and a study of the experimental dimethoate
EC35 formulation. See Table 2 for numbers of animals in each group. Each study was
carried out separately in an intensive care laboratory, starting between 07:00 and
08:00.
The  individual animal was  the experimental unit. Bias was  minimised by ran-
domly allocating animals to study groups using a random number list. Allocation
could not be predicted before allocation; the study was an open study but the
outcomes were robust and not likely to be affected by bias (Wood et al., 2008).
2.2. Anaesthesia
Pre-anaesthetic medication was intramuscular injections of ketamine (5 mg/kg)
and  midazolam (0.5 mg/kg). Anaesthesia was induced with 5% isoﬂurane [selected
since the effect of this anaesthetic on AChE activity is well characterised (Dorandeu
et  al., 2007)] in oxygen delivered via facemask. The trachea was intubated and
anaesthesia maintained to a clinically acceptable depth using isoﬂurane in oxygen
delivered via a circle breathing system. Intermittent positive pressure ventilation
(IPPV) was provided as necessary using a minute volume divider (Manley Pul-
movent, Harlow, UK) adjusted to maintain normocapnia.
Inspired and expired carbon dioxide, oxygen and isoﬂurane concentrations were
monitored. Heart rate, oesophageal and peripheral temperature, electrocardiogram,
and percentage of saturated haemoglobin were recorded (Datex, USA). Temperature
was  maintained as close to physiological values as possible by the use of forced warm
air  blankets (Bair Hugger, Arizant UK) or heat pads and a high ambient temperature.
Ten  ml/kg/h lactated Ringer’s solution was administered for the ﬁrst 30 min after
induction of anaesthesia and then at 5 ml/kg/h for the remainder of the study. Fluid
administration was increased as necessary during the study to maintain urine output
and raise the central venous pressure.
2.3. Instrumentation and monitoring
A central arterial catheter was placed surgically into the carotid artery for con-
tinuous arterial pressure monitoring. A central venous catheter was placed into the
external jugular vein for infusion of drugs and monitoring of central venous pres-
sure. The catheters were connected to a pressure manometer (Datex, USA) zeroed
at  the level of the base of the heart to give arterial and CVP pressure readings.
Lithium dilution cardiac output (LiDCO, London, UK) was  used to assess beat-to-
beat cardiac output, arterial blood pressure, and systemic vascular resistance (SVR).
A  urine catheter was placed by mini-laparotomy; urine output was  measured every
60–120 min. An orogastric tube was  placed for poison gavage.
IPPV was  withdrawn every 30 min to assess the pig’s ability to breathe spon-
taneously. The time to return of spontaneous ventilation (SV) and the EtCO2 after
30 s of SV were recorded. IPPV was then re-imposed to help maintain cardiovascular
stability.
Mechanomyography was established using the deep peroneal nerve/tibialis pos-
terior nerve/muscle group. Train of four stimulations was applied at 2 Hz, at intervals
greater than 10 s, as per standard protocols (Fuchs-Buder et al., 2009).
2.4. Experimental protocol
After arterial catheter insertion, 60 min was allowed to pass before poisoning
during which time baseline observations were recorded. Minipigs were randomly
allocated to each group. Pigs were administered 2.5 ml/kg of dimethoate 40% emul-
siﬁable concentrate (EC40; BASF SE, Ludwigs-hafen, Germany), 2.5 ml/kg saline
placebo, 1 g/kg dimethoate AI (BASF), 1 g/kg cyclohexanone (Fluka-Sigma, Poole,
UK), 1 g/kg xylene (Fluka-Sigma, Poole, UK), 1 g/kg dimethoate AI dissolved in
cyclohexanone (1 ml/kg dose of cyclohexanone), or 2.5 ml/kg of dimethoate 40%
emulsiﬁable concentrate lacking cyclohexanone (EC35; Cheminova A/S, Harboøre,
Denmark), by gavage all followed by 60 ml  of water. The quantity of each compound
in each study represented the quantity present in a 2.5 ml/kg dose of agricultural
dimethoate EC40. This allowed the results of each study to be compared with the
original dimethoate EC40 study.
The initial dose of dimethoate EC40 was selected as being towards the mid-
dle  range of the estimated dose in human self-poisoning (bottle sizes 100–400 ml
(Eddleston et al., 2005), mean weight of self-poisoned patients 50 kg (Eddleston
et  al., 2000); likely dose range 0.1 to 8 ml/kg). Dose response studies with a 50%
reduction in dimethoate EC40 dose caused mild poisoning that did not require high
doses of noradrenaline (Eddleston et al., manuscript in preparation). The severe poi-
soning elicited by 2.5 ml/kg dimethoate EC40 allowed the components of the toxicity
to  be studied.
Noradrenaline was administered to maintain a MAP >55 mmHg, with a target
MAP  of 65 mmHg. Two hours post-dimethoate (EC or AI) or saline administration,
a  bolus of pralidoxime chloride (8 mg/kg) was given over 30 min followed by an
infusion of 3.5 mg/kg/h until the end of the study. Atropine was administered as
required to control muscarinic features. The study was ended by euthanasia using
pentobarbital or anaesthetic overdose after 12 h.
2.5. Measurements
Cardiovascular data were collected 30 and 10 min before poisoning and 15 min
intervals thereafter using LiDCO. Arterial blood samples were taken at −40, −10, and
30  min, and then every hour, and lactate analysed using an i-STAT (Abbott, NJ, USA).
Analyses for red cell AChE activity were performed as previously described (Worek
et  al., 1999; Eddleston et al., 2005). Dimethoate and its active metabolite omethoate
were detected by LC-ESI-MS/MS and FI-ESIMS/MS (Eddleston et al., 2005; John et al.,
2010).
Cyclohexanone and cyclohexanol were quantiﬁed using a Thermo Scientiﬁc
Trace gas chromato-graph ﬁtted with an AS2000 autosampler and a ﬂame ionisation
detector. Plasma samples were prepared by thawing from −80 ◦C at room tempera-
ture, then 1 ml  aliquots were spun in a micro-centrifuge for 5 min  at 10,000 rpm
to  pellet any solid matter. 200 l of supernatant was added to an autosampler
vial containing 20 l of 2 g/100 ml  iso-amyl alcohol (internal standard) in water.
One l volumes of this mixture were injected and analysed using a HP-Innowax
30  m ×0.53 mm × 1 m ﬁlm thickness capillary column and the following condi-
tions: injector temperature 240 ◦C, split ratio 6:1, carrier gas (helium) ﬂow rate
1.8  ml/min, oven temperature programmed between 80 and 200 ◦C (2 min at 80 ◦C,
then  15 ◦C/min increase to 200 ◦C); detector temperature 270 ◦C with hydrogen and
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Table 1
Constituents of the dimethoate EC40 (BASF) formulation used in agriculture.
Constituent CAS number Role Amount (g/l) Toxicity (rat oral LD50, mg/kg) Number of rat oral LD50/kg
in 2.5 ml/kg
Dimethoate 60-51-5 Active ingredient 40 250 (World Health Organization, 2010) 4
Cyclohexanone 108-94-1 Solvent 40 1620 (Smyth et al., 1969) 0.62
Xylene 1330-20-7 Solvent 5 ∼5000 (International Programme on Chemical Safety, 1997) 0.025
Wettol Surfactant NK Low NK
The surfactant, Wettol, is not described on the Product Safety Information Sheet and is therefore likely to have been non-hazardous in rat studies. It is a propriety compound
and  does not have a CAS number. Abbreviations: CAS, Chemical Abstract Service; NK, not known.
air  ﬂow rates of 35 and 350 ml/min, respectively. Cyclohexanol, cyclohexanone and
ethanol were quantiﬁed using an internal standard method with calibration over
the  range 0–10 mM.
2.6. Outcomes
The primary outcome for the study was  arterial lactate concentration over the
12  h of the study; secondary outcomes were SVR, noradrenaline requirements, and
red cell acetylcholinesterase activity over the 12 h of the study.
2.7. Power calculation
No data was  available for calculating sample sizes before the study started.
Groups of around ﬁve pigs were selected for the ﬁrst study. Our choice of subse-
quent sample size was  based on the experience from our ﬁrst experiment and on
minimising the use of animals.
2.8. Statistical analysis
We did primary data analysis in Prism 5.0 (GraphPad, San Diego, CA). All ani-
mals were included in the analysis. Pig weights were summarised with mean and
SD;  clinical and biochemical outcomes were summarised with mean and SEM. Due
to  the small number of animals, and our aim to include as much data in the analy-
sis  as possible, we  compared the area under the curve for the outcomes of different
minipig groups. All groups were compared using a Kruskal–Wallis test; if signiﬁcant,
we  then performed pairwise comparisons with a non-parametric Mann–Whitney
test. P-values obtained from the pairwise comparisons were adjusted for multi-
ple  comparisons using the FDR method (Benjamini and Hochberg, 1995). This was
performed using the R Software Package version 2.14. Statistical signiﬁcance was
accepted at P < 0.05 for all tests.
3. Results
3.1. Agricultural dimethoate causes severe toxicity
Dimethoate EC40 2.5 ml/kg (containing 1 g/kg active ingredi-
ent [AI] dimethoate) given by gavage resulted in respiratory arrest
within 30 min; spontaneous breathing did not recur during the
12 h study. Noradrenaline (NA) was soon required to maintain the
mean arterial pressure (MAP) above 55 mmHg  (target 65 mmHg)
due to a rapid fall in systemic vascular resistance (SVR; Fig. 1).
The SVR and MAP  continued to fall, requiring increasing doses
of NA; there was a concurrent rise in heart rate, stroke volume,
and cardiac output (data not shown), as well as arterial blood
lactate (to 15.6 [SD 2.8] mmol/l at 12 h). Administration of saline
placebo produced only minor changes in SVR and MAP, and no rise
in arterial blood lactate (1.4 [SD 0.8] mmol/l at 12 h, P < 0.0268;
Fig. 1, Table 2). Monitoring of neuromuscular junction (NMJ) func-
tion by mechanomyography (MMG)  showed gradual dysfunction
in dimethoate EC40 poisoned pigs (Fig. 2).
Pralidoxime chloride was administered at 2 h post-poisoning;
examination of red cell AChE activity showed little reactivation
(Fig. 1E). In addition, red cell AChE assays showed that the respi-
ratory failure and the initial distributive shock (both of which
occurred within 30 min  of ingestion) occurred before AChE activity
had fallen by more than 70%. This suggests that AChE inhibition
alone is not responsible for clinical toxicity, since human stud-
ies indicate that >70% inhibition is required for clinical illness
(Thiermann et al., 2005).
3.2. Dimethoate AI and cyclohexanone reproduced agricultural
dimethoate’s toxicity
To test whether coformulants might be responsible for toxic-
ity, we  then prepared solutions of (i) technical grade dimethoate AI
alone, (ii) cyclohexanone alone, (iii) xylene alone (data not shown),
and (iv) dimethoate AI and cyclohexanone together. Each com-
pound was  given at a dose of 1 g/kg, reproducing their dose in the
EC40 formulation, except for xylene (8-fold larger quantity than
present in dimethoate EC40) (Table 1). Pralidoxime was given to
Table 2
Comparisons of lactate concentration, SVR, noradrenaline requirements, and red cell AChE between study groups.
Group AUC (1–12 h)
Mean (SEM)
Comparison with
Saline control
Comparison with
Dimethoate EC40
AUC (1–12 h)
Mean (SEM)
Comparison with
Saline control
Comparison with
Dimethoate EC40
Arterial lactate SVR
Saline control (n = 5) 16.0 (2.3) N/A P = 0.0268 5423 (244) N/A P = 0.0358
Dimethoate EC40 (n = 7) 98.4 (8.5) P = 0.0268 N/A 1151 (169) P = 0.0358 N/A
Dimethoate AI (n = 3) 48.0 (6.8) P = 0.0402 P = 0.0285 2979 (442) P = 0.0490 P = 0.0428
Cyclohexanone (n = 4) 42.7 (5.4) P = 0.0268 P = 0.0268 3013 (748) P = 0.0714 P = 0.0358
Dim  AI + cyclo (n = 4) 72.2 (13.3) P = 0.0268 P = 0.1554 1314 (100) P = 0.0358 P = 0.4762
Dimethoate EC35 (n = 4) 52.6 (5.9) P = 0.0268 P = 0.0268 2176 (229) P = 0.0358 P = 0.0490
Group  AUC (1–12 h)
Mean (SEM)
Comparison with
Saline control
Comparison with
Dimethoate EC40
AUC (1–12 h)
Mean (SEM)
Comparison with
Saline control
Comparison with
Dimethoate EC40
Noradrenaline requirements Red cell AChE activity
Saline control 0.07 (0.1) N/A P = 0.0376 1303 (42) N/A P = 0.0183
Dimethoate EC40 11.3 (2.9) P = 0.0376 N/A 310 (19) P = 0.0183 N/A
Dimethoate AI 0.77 (0.1) P = 0.0393 P = 0.0376 253 (35) P = 0.0536 P = 0.1500
Cyclohexanone 2.09 (1.1) P = 0.1043 P = 0.0393 1304 (310) P = 0.4127 P = 0.0183
Dim  AI + cyclo 10.2 (0.7) P = 0.0376 P > 0.999 413 (53) P = 0.0286 P = 0.3546
Dimethoate EC35 24.0 (6.6) P = 0.0376 P = 0.1227 200 (6) P = 0.0286 P = 0.0183
All groups were compared using a Kruskal–Wallis test; since this comparison was signiﬁcant, we  then performed pairwise comparisons with a non-parametric Mann–Whitney
test  with adjustment of multiple comparisons using the FDR method.
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Fig. 1. Cardiovascular and biochemical consequences of oral poisoning with dimethoate EC40 pesticide in Gottingen minipigs. (A) Systemic vascular resistance, (B) mean
arterial pressure, (C) noradrenaline requirements, (D) arterial lactate concentration, and (E) red cell AChE activity in dimethoate EC40 (red squares) and saline placebo
(blue  rings) poisoned minipigs. Pralidoxime was  administered from 2 h post poison administration. (F) Plasma concentration of dimethoate (brown squares), and its active
metabolite omethoate (green circles), and of (G) the main solvent cyclohexanone (brown squares), and its metabolite cyclohexanol (green diamond), in minipigs poisoned
with  dimethoate EC40. The graphs show data over the 12 h of the study; mean ± SEM, n = 5–7 pigs. (For interpretation of the references to color in this ﬁgure legend, the
reader  is referred to the web version of the article.)
pigs receiving dimethoate AI. Pigs receiving cyclohexanone alone
or dimethoate AI alone had modest falls in SVR and MAP  that did
not require large doses of NA or result in a marked rise in arterial
lactate (Fig. 3A–F). Xylene showed no toxicity (data not shown).
However, pigs given dimethoate AI and cyclohexanone together
showed identical toxicity to dimethoate EC40 with rapid respira-
tory arrest, severe distributive shock, marked rise in arterial lactate
(Fig. 3A–F, Table 2), and NMJ  dysfunction.
The modest effects of dimethoate AI or cyclohexanone alone
was  not due to reduced absorption. Analysis of red cell AChE
activity showed similar inhibition with dimethoate AI and EC40
(Fig. 3G and H). There was  no pralidoxime-induced reactivation
of AChE inhibited by dimethoate AI. The plasma concentration for
dimethoate and its active metabolite, omethoate, were similar dur-
ing the ﬁrst 4 h post-poisoning (Fig. 4) when marked differences
in clinical syndrome were apparent. Similarly, concentrations of
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Fig. 2. Neuromuscular function in poisoned minipigs. Neuromuscular function shown by mechanomyography in pigs poisoned with saline placebo, dimethoate EC40, and
dimethoate AI at baseline. NMJ  dysfunction is clearly visible at 6 h in pigs poisoned by dimethoate EC40; NMJ  function was normal throughout the study in the other pigs.
Four  stimuli were produced at 2 Hz as per standard TOF methodology (Fuchs-Buder et al., 2009).
plasma cyclohexanone and its metabolite, cyclohexanol, soon after
poisoning were similar in pigs receiving the three formulations con-
taining cyclohexanone (Fig. 4). However, plasma concentrations
of cyclohexanol were 3-fold higher at later time points in pigs
receiving dimethoate EC40 or dimethoate AI + cyclohexanone than
cyclohexanone alone.
3.3. Agricultural dimethoate without cyclohexanone is less toxic
We then tested an experimental EC formulation (dimethoate
EC35) that also contained 400 g/l dimethoate but no cyclohex-
anone. Administration of 2.5 ml/kg resulted in no respiratory
arrest or NMJ  dysfunction. The cardiovascular toxicity was simi-
lar to dimethoate EC40, with requirements for large doses of NA
(Fig. 5C; Table 2). However, the rise in mean arterial lactate (to
7.0 [SD2.8] mmol/l at 12 h; Fig. 5B, Table 2) occurred more slowly.
Of note, despite the less severe respiratory toxicity and smaller
rise in lactate noted in this model, red cell AChE inhibition was
more severe (Fig. 5D; Table 2) and omethoate plasma concentration
greater than following poisoning with the EC40 formulation (Fig. 4),
again suggesting that factors other than the OP determine toxicity.
4. Discussion
In this work, we developed a model of OP pesticide poisoning
that is highly relevant to human self-poisoning. We  used a relevant
dose of formulated agricultural dimethoate, given by a relevant
route, to a species with many physiological and metabolic sim-
ilarities to humans, treated in a similar way to human patients.
The severe cardiovascular shock and neuromuscular dysfunction,
and lack of effect of pralidoxime, that resulted was  very similar
to human dimethoate poisoning. Treatment of poisoned patients
is difﬁcult with a high case fatality for severely poisoned patients.
Fifty years of animal research has not brought a single new treat-
ment into clinical use (Buckley et al., 2004). This clinically relevant
model may  be useful for testing novel antidotes.
We  found that the severe toxicity was not due only to the
dimethoate AI itself. Instead, the cyclohexanone solvent was
required for toxicity – its absence resulted in no neuromuscular
toxicity and markedly attenuated cardiotoxicity. Poisoning with an
experimental formulation of agricultural dimethoate that lacked
cyclohexanone produced less toxicity.
These results clearly indicate that the toxicity of the agricultural
dimethoate preparations ingested for self-harm in rural Asia is due
to both the dimethoate AI and its major solvent cyclohexanone.
Each compound alone is unable to cause severe toxicity. This ﬁnding
has profound public health and clinical implications.
OP insecticides have been formulated to enhance their agri-
cultural efﬁcacy and safety, not to make them safer for human
self-poisoning. This might seem reasonable, since the bottle label
clearly states that the insecticide should not be drunk. However,
farming in the developing world is stressful, and self-harm with
insecticides (Eddleston and Phillips, 2004), whether due to crop
failure, indebtness, alcoholism, or simple social stresses, must be
thought of as an occupational hazard of farming practices in which
widespread and easy access to pesticides is encouraged by gov-
ernment and industry. In this case, reformulation of pesticides to
make them less toxic to humans should be a priority. The intro-
duction of less toxic OP pesticides into agricultural practice should
markedly reduce suicide rates, as shown by Sri Lanka’s experience
in the mid-1990s when method substitution was minimal (Gunnell
et al., 2007b; de Silva et al., 2012).
Unfortunately, risk assessment of pesticide toxicity concen-
trates on the active ingredient, not on the other constituents of
the formulated pesticides, as shown by recent FAO and EPA assess-
ments performed on dimethoate (US Environmental Protection
Agency Ofﬁce of Pesticide Programs, 2008; Food and Agricultural
Organization, 2005). For formulated products, toxicity information
usually only consists of acute toxicity data generated in rodents
for the purpose of classiﬁcation and labelling. There is relatively
little knowledge about the comparative toxicity of differently for-
mulated pesticides or the role of coformulants in overall acute
toxicity.
The importance of solvents in dimethoate toxicity may  explain
in part the inability of pralidoxime to markedly improve outcome
for patients poisoned with WHO  Class II OP insecticides (Eddleston
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Fig. 3. Cardiovascular and biochemical consequences of oral poisoning with dimethoate EC40 pesticide, dimethoate AI, and/or cyclohexanone in Gottingen minipigs. (A
and  B) systemic vascular resistance (SVR), (C and D) noradrenaline requirements, (E and F) arterial lactate concentration, and (G and H) red cell AChE activity in groups of
pigs  poisoned with saline placebo (blue circles), dimethoate EC40 (red squares), dimethoate AI (green triangles), cyclohexanone (purple diamonds) and dimethoate AI plus
cyclohexanone (blue-green diamonds). The saline and dimethoate EC40 data from Fig. 1 are repeated here to contrast the effect of different poisons. The graphs show data
over  the 12 h of the study; mean ± SEM, n = 3–6 pigs. The dot plots show the AUC and median for each group. Comparison of all groups with a Kruskal–Wallis test indicated
signiﬁcant differences for all four variables. The results of pairwise comparisons using the Mann–Whitney test are given in the ﬁgures (*P < 0.05 and **P  < 0.01 compared to
saline  placebo; #P < 0.05 and ##P < 0.01 compared to dimethoate EC40). Abbreviations: cyclo, cyclohexanone; dim, dimethoate. (For interpretation of the references to color
in  this ﬁgure legend, the reader is referred to the web version of the article.)
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et al., 2009a; Buckley et al., 2011). There is currently no speciﬁc
antidote for solvents; oximes may  be addressing only part of the
toxicity. Namba showed clearly in the 1950s that pralidoxime ben-
eﬁted patients unintentionally poisoned with the more toxic WHO
Class I OP insecticides such as parathion (Namba and Hiraki, 1958;
Namba et al., 1959). This may  be due to lower level occupational
exposure; however, it may  also be because the quantity of sol-
vent present in a lethal dose of parathion is markedly less than
in a ‘moderately toxic’ WHO  Class II OP, reducing the importance
of coformulants. This situation is also likely to be quite different
after poisoning with OP nerve agents (e.g. sarin) in which there
are no solvents and the onset is much faster, making it likely that
AChE inhibition is responsible for all toxic features (Maxwell et al.,
2006).
Toxicokinetic and dynamic studies indicated that the differences
were not due to variation in absorption alone. Red cell AChE activ-
ity in pigs poisoned with dimethoate EC40 and dimethoate AI were
identical, despite very different poisoning severity. This discrep-
ancy raises questions about the usefulness of this biomarker in OP
pesticide poisoning (Eddleston et al., 2009a,b; Eyer et al., 2010).
Plasma dimethoate and omethoate concentrations were simi-
lar in the ﬁrst few hours after poisoning with dimethoate EC40,
dimethoate AI, and dimethoate AI + cyclohexanone, when differ-
ences in toxicity were apparent. The dimethoate and omethoate
concentrations after poisoning with dimethoate AI then decreased.
The dimethoate concentration after poisoning with the new
dimethoate EC formulation was markedly less than with the
other formulations; however, the omethoate concentration was
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signiﬁcantly higher and red cell AChE more inhibited, suggesting
again that pesticide toxicokinetic differences were not the basis for
the differences in toxicity.
Plasma cyclohexanol concentrations were substantially lower
after poisoning with cyclohexanone alone compared to dimethoate
EC40 or dimethoate + cyclohexanone. Plasma cyclohexanone con-
centrations were also lower after cyclohexanone compared to
dimethoate EC40 but less so than its metabolite. These differences
suggest that the presence of dimethoate alters metabolism of the
solvent; it is known that dimethoate induces cytochrome P450
activity and its own metabolism (Buratti and Testai, 2007). There
was little evidence for dimethoate increasing the absorption of
cyclohexanone.
The mechanism for the effect of cyclohexanone on dimethoate
toxicity is unclear. Both dimethoate AI and cyclohexanone caused
a fall in systemic vascular resistance; it is possible that their effects
are additive. Alternatively, the solvent may  alter the distribution
of the dimethoate and thereby alter toxicity. Further studies are
required to address this point.
We used arterial lactate concentration as a marker of
global toxicity. Its substantial increase in pigs poisoned with
dimethoate and cyclohexanone probably represents a combi-
nation of tissue hypoxia, hepatic dysfunction reducing lac-
tate clearance, and catecholamine-induced changes in muscle
metabolism.
The main limitation of this study is that it was  performed in
anaesthetised minipigs and not humans. An anaesthetised minipig
is clearly different to self-poisoned humans and we cannot be sure
that the results are a “true reﬂection” of the human situation. How-
ever, such a study is not possible in humans and pigs have multiple
similarities to humans (McAnulty et al., 2011), increasing the rel-
evance of these results. The great majority of previous research
studies for investigation of OP antidotes have been done in rodents.
These studies have limited relevance to acute human toxicity as
seen in self-poisoning: rodents metabolize xenobiotics differently
to humans (Martignoni et al., 2006; Tang et al., 2001). In addition,
the OP compound has usually been given by an irrelevant route
(e.g. intravenous), as an unformulated AI, and the rodent has not
been treated with supportive care (ventilation, vasopressors) as
occurs for humans. Our model is more relevant to human poison-
ing, with the pesticide given by the correct route and formulation
to a species that has physiological and biochemical similarities to
human, receiving typical supportive care. This relevance is appar-
ent in the similarity of the poisoning seen in these minipigs and
poisoned humans, with the same clinical syndrome, AChE inhibi-
tion, and response to pralidoxime (Davies et al., 2008; Eddleston
et al., 2005). Although in vitro studies indicate that pig AChE inhib-
ited by highly toxic OP nerve agents is less well activated by oximes
than similarly inhibited human AChE (Aurbek et al., 2006; Worek
et al., 2008), this is moot here since human AChE is not reactivated
by pralidoxime – the same situation as we found in our pig model.
Use of such a model in future animal studies will reduce the number
of animals used (3Rs).
Due to welfare issues, the animals were anaesthetised with
isoﬂurane for the study. Although the use of anaesthesia is another
limitation, all arms of the study had identical anaesthesia and this
could not explain the differences seen. Isoﬂurane anaesthesia was
selected since it has a consistent and mild (about 10%) inhibitory
effect on AChE activity (Dorandeu et al., 2007). The animals were
anaesthetised for about 1.5 h before poison administration. Differ-
ences between arms of the study were apparent within 30 min,
making it unlikely in this time frame that induction of CYP enzymes
involved in the metabolism of OPs could be involved in the differ-
ences seen.
In conclusion, this study indicates that dimethoate AI is not
solely responsible for toxicity in the pig. Instead, coformulants are
an important element of OP toxicity; therefore their toxicity should
be considered by manufacturers, regulators and clinicians. Further
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studies are required to determine the generality of this ﬁnding and
how formulations can be changed to improve human safety without
reducing agricultural efﬁcacy.
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